Baylor College of Medicine,
(United States of America)
Acute Coronary Syndromes
Follow me on:
Dr. Chayakrit Krittanawong is a clinician-scientist interested in precision medicine, using the integrative omics and emerging technologies such as artificial intelligence or blockchain to assist physicians and patients worldwide. He has been involved with numerous investigational studies in cardiovascular medicine as a principal investigator. He has been the primary author of publications in Circulation, Journal of the American College of Cardiology (JACC), European Heart Journal, JAMA Cardiology, Nature Review Cardiology, JACC Imaging, Heart, and BMJ innovation. He serves as a reviewer for multiple journals, including The Lancet, Nature Genetics, Annals of Internal Medicine, Circulation, JACC, JAMA Cardiology, Journal of the American Heart Association (JAHA), Lancet Digital Health, JACC Imaging, JACC Cardiovascular Interventions and Journal of Graduate Medical Education (JGME). Dr. Krittanawong serves on the ACC Guidelines and Documents Task Forces on the Solution Set.
ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.
Our mission: To reduce the burden of cardiovascular disease